Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

被引:309
|
作者
Kmiecik, Justyna [1 ]
Poli, Aurelie [1 ]
Brons, Nicolaas H. C.
Waha, Andreas [2 ]
Eide, Geir Egil [3 ,4 ]
Enger, Per Oyvind [5 ]
Zimmer, Jacques
Chekenya, Martha [1 ,6 ]
机构
[1] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway
[2] Univ Hosp, Dept Neuropathol, Bonn, Germany
[3] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[4] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway
[5] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[6] Univ Bergen, Dept Clin Dent, N-5009 Bergen, Norway
关键词
GBM; Tumor infiltrating cells; Regulatory T cells; Antigen presenting cells; REGULATORY T-CELLS; MGMT PROMOTER METHYLATION; NATURAL-KILLER-CELLS; NK CELLS; ADJUVANT TEMOZOLOMIDE; PROGNOSTIC VALUE; RECEPTOR; CANCER; EXPRESSION; NKG2D;
D O I
10.1016/j.jneuroim.2013.08.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We characterized GBM patients' tumor and systemic immune contexture with aim to reveal the mechanisms of immunological escape, their impact on patient outcome, and identify targets for immunotherapy. Increased CD3 T-cell infiltration was associated with prolonged survival independent of age, MGMT promoter methylation and post-operative treatment that implies potential for immunotherapy for GBM. Several mechanisms of escape were identified: within the tumor microenvironment: induced cD8+cD28 Foxp3 Tre that may tolerize antigen presenting cells, elevated CD73 and CD39 ectonucleotidases that suppress T-cell function, and at the systemic level: elevated IL-10 levels in serum, diminished helper T-cell counts, and upregulated inhibitory CTLA-4. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 83
页数:13
相关论文
共 50 条
  • [41] Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
    Alsalman, Alhasan
    Al-Mterin, Mohammad A.
    Murshed, Khaled
    Alloush, Ferial
    Al-Shouli, Samia T.
    Toor, Salman M.
    Elkord, Eyad
    CANCERS, 2022, 14 (13)
  • [42] Angioimmunoblastic T-cell lymphoma with predominant CD8+tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment
    Chen, Zihang
    Zhu, Qiqi
    Deng, Xueqin
    Yao, Wenqing
    Zhang, Wenyan
    Liu, Weiping
    Tang, Yuan
    Zhao, Sha
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients
    Yu Qi
    Yu Xia
    Zhiyuan Lin
    Yang Qu
    Yangyang Qi
    Yifan Chen
    Quan Zhou
    Han Zeng
    Jiajun Wang
    Yuan Chang
    Qi Bai
    Yiwei Wang
    Yu Zhu
    Le Xu
    Lingli Chen
    Yunyi Kong
    Weijuan Zhang
    Bo Dai
    Li Liu
    Jianming Guo
    Jiejie Xu
    Cancer Immunology, Immunotherapy, 2020, 69 : 1565 - 1576
  • [44] Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients
    Qi, Yu
    Xia, Yu
    Lin, Zhiyuan
    Qu, Yang
    Qi, Yangyang
    Chen, Yifan
    Zhou, Quan
    Zeng, Han
    Wang, Jiajun
    Chang, Yuan
    Bai, Qi
    Wang, Yiwei
    Zhu, Yu
    Xu, Le
    Chen, Lingli
    Kong, Yunyi
    Zhang, Weijuan
    Dai, Bo
    Liu, Li
    Guo, Jianming
    Xu, Jiejie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (08) : 1565 - 1576
  • [45] CD3+ and CD8+ tumor-infiltrating lymphocyte (TIL) densities to prognostically stratify DNA mismatch repair-deficient (dMMR) colon cancer patients (pts): NCCTG N0147 (Alliance).
    Yoon, Harry H.
    Shi, Qian
    Heying, Erica N.
    Muranyi, Andrea
    Ough, Faith
    Djalilvand, Azita
    Yoon, Harry H.
    Shi, Qian
    Heying, Erica N.
    Muranyi, Andrea
    Ough, Faith
    Djalilvand, Azita
    Clements, June
    Bowermaster, Rebecca
    Liu, Wen-Wei
    Barnes, Michael
    Alberts, Steven R.
    Shanmugam, Kandavel
    Sinicrope, Frank A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Tumor-Infiltrating FoxP3+Tregs and CD8+T Cells Affect the Prognosis of Hepatocellular Carcinoma Patients
    Huang, Yong
    Wang, Feng-mei
    Wang, Tao
    Wang, Yi-jun
    Zhu, Zheng-yan
    Gao, Ying-tang
    Du, Zhi
    DIGESTION, 2012, 86 (04) : 329 - 337
  • [47] Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis
    Johansson, Junko
    Siarov, Jan
    Kiffin, Roberta
    Molne, Johan
    Mattsson, Jan
    Naredi, Peter
    Olofsson Bagge, Roger
    Martner, Anna
    Lindner, Per
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [48] Machine learning models based on quantitative dynamic contrast-enhanced MRI parameters assess the expression levels of CD3+, CD4+, and CD8+ tumor-infiltrating lymphocytes in advanced gastric carcinoma
    Huang, Huizhen
    Li, Zhiheng
    Wang, Dandan
    Yang, Ye
    Jin, Hongyan
    Lu, Zengxin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [49] Tumor-infiltrating, interleukin-33-producing effector-memory CD8+ T cells in resected hepatocellular carcinoma prolong patient survival
    Brunner, Stefan M.
    Rubner, Christoph
    Kesselring, Rebecca
    Martin, Maria
    Griesshammer, Eva
    Ruemmele, Petra
    Stempfl, Thomas
    Teufel, Andreas
    Schlitt, Hans J.
    Fichtner-Feigl, Stefan
    HEPATOLOGY, 2015, 61 (06) : 1957 - 1967
  • [50] Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value
    Mazzaschi, Giulia
    Madeddu, Denise
    Falco, Angela
    Bocchialini, Giovanni
    Goldoni, Matteo
    Sogni, Francesco
    Armani, Giovanna
    Lagrasta, Costanza Annamaria
    Lorusso, Bruno
    Mangiaracina, Chiara
    Vilella, Rocchina
    Frati, Caterina
    Alfieri, Roberta
    Ampollini, Luca
    Veneziani, Michele
    Silini, Enrico Maria
    Ardizzoni, Andrea
    Urbanek, Konrad
    Aversa, Franco
    Quaini, Federico
    Tiseo, Marcello
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 407 - 419